APLS icon

Apellis Pharmaceuticals

143 hedge funds and large institutions have $1.53B invested in Apellis Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 63 increasing their positions, 34 reducing their positions, and 23 closing their positions.

Holders
143
Holders Change
+10
Holders Change %
+7.52%
% of All Funds
3.16%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
35
Increased
63
Reduced
34
Closed
23
Calls
$5.35M
Puts
$11.4M
Net Calls
-$6.06M
Net Calls Change
-$13.1M
Name Market Value Shares Shares
Change
Shares
Change %
SSA
151
Schonfeld Strategic Advisors
New York
-41,067 Closed
PAMU
152
Pictet Asset Management (UK)
United Kingdom
-37,386 Closed
IHAM
153
Integral Health Asset Management
New York
-35,000 Closed
MWNA
154
Marshall Wace North America
New York
-22,343 Closed
ACM
155
Asymmetry Capital Management
California
-21,380 Closed
Renaissance Technologies
156
Renaissance Technologies
New York
-19,513 Closed
ECM
157
Endurant Capital Management
California
-19,362 Closed
Ameriprise
158
Ameriprise
Minnesota
-19,200 Closed
Voloridge Investment Management
159
Voloridge Investment Management
Florida
-16,762 Closed
AC
160
Athanor Capital
New York
-16,300 Closed
QSS
161
Quantitative Systematic Strategies
Florida
-11,449 Closed
GCP
162
GSA Capital Partners
United Kingdom
-10,461 Closed
Jane Street
163
Jane Street
New York
-8,135 Closed
FC
164
FORA Capital
Florida
-2,156 Closed
Federated Hermes
165
Federated Hermes
Pennsylvania
-1,434 Closed
TRCT
166
Tower Research Capital (TRC)
New York
-270 Closed
CL
167
CSS LLC
Illinois
WVP
168
Worth Venture Partners
New Jersey
Group One Trading
169
Group One Trading
Illinois
CFGS
170
Concourse Financial Group Securities
Alabama
CM
171
Caption Management
Oklahoma
Walleye Capital
172
Walleye Capital
New York